TD Cowen Maintains Hold on Legend Biotech, Raises Price Target to $29

Benzinga Newsdesk www.benzinga.com Positive 66.9%

Neg 0% Neu 0% Pos 66.9%

TD Cowen analyst Yaron Werber maintains Legend Biotech (NASDAQ:LEGN) with a Hold and raises the price target from $21 to $29.